ClinicalTrials.govpublic full text
Biomarker-based Trial of NPC-1 for Alzheimer's Pathology
alzheimer disease, mild cognitive impairment (mci), subjective cognitive decline (scd), open label, dietary supplements, alzheimer's disease, intervention, early phase clinical trial, blood based biomarkers, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 897412
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.